Radical trimodality therapy for patients with locally advanced bladder cancer: The British Columbia Cancer Agency experience

International Agency for Research on Cancer. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization. Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx [accessed 31.03.14.]. Witjes JA, Compérat E, Cowan NC, et al. Guidelines on muscle-invasive and metastatic bladder cancer. Uroweb 2013. Available from: http://www.uroweb.org/gls/pdf/07_Bladder%20Cancer_LRV2.pdf [accessed 31.03.14.]. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Bladder Cancer Version 1.2014. Available from: http://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf [accessed 31.03.14.]. Tester, 1993, Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12, Int J Radiat Oncol Biol Phys, 25, 783, 10.1016/0360-3016(93)90306-G Tester, 1996, Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group Phase II Trial 8802, J Clin Oncol, 14, 119, 10.1200/JCO.1996.14.1.119 Shipley, 1998, Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03, J Clin Oncol, 16, 3576, 10.1200/JCO.1998.16.11.3576 Kaufman, 2009, Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy, Urology, 73, 833, 10.1016/j.urology.2008.09.036 Shipley, 2003, Overview of bladder cancer trials in the Radiation Therapy Oncology Group, Cancer, 97, 2115, 10.1002/cncr.11282 Shipley, 2002, Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer, Urology, 60, 62, 10.1016/S0090-4295(02)01650-3 Coppin, 1996, Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation, J Clin Oncol, 14, 2901, 10.1200/JCO.1996.14.11.2901 2009 Kaplan, 1958, Non-parametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Pos, 2006, Radical radiotherapy for invasive bladder cancer: what dose and fractionation schedule to choose?, Int J Radiat Oncol Biol Phys, 64, 1168, 10.1016/j.ijrobp.2005.09.023 Yafi, 2009, Radical cystectomy is the treatment of choice for invasive bladder cancer, Can Urol Assoc J, 3, 409, 10.5489/cuaj.1156 Quek, 2005, Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy, J Urol, 174, 103, 10.1097/01.ju.0000163267.93769.d8 Madersbacher, 2003, Radical cystectomy for bladder cancer today—a homogeneous series without neoadjuvant therapy, J Clin Oncol, 21, 690, 10.1200/JCO.2003.05.101 Sauer, 1998, Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer, Int J Radiat Oncol Biol Phys, 40, 121, 10.1016/S0360-3016(97)00579-8 Manoharan, 2009, Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome, Br J Urol, 104, 1227, 10.1111/j.1464-410X.2009.08625.x Dalbagni, 2001, Cystectomy for bladder cancer: a contemporary series, J Urol, 165, 1111, 10.1016/S0022-5347(05)66440-3 Brown, 2001, An organ-preserving approach to muscle-invading transitional cell cancer of the bladder, Hematol Oncol Clin North Am, 15, 345, 10.1016/S0889-8588(05)70216-1 Stenzl, 2011, Treatment of muscle-invasive and metastatic bladder cancer: update of EAU guidelines, Eur Urol, 59, 1009, 10.1016/j.eururo.2011.03.023 James, 2012, Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer, N Engl J Med, 366, 1477, 10.1056/NEJMoa1106106 Shariat, 2007, Discrepancy between clinical and pathological stage: Impact on prognosis after radical cystectomy, Eur Urol, 51, 137, 10.1016/j.eururo.2006.05.021